Cargando…
Estimating Systolic Blood Pressure Intervention Trial Participant Posttrial Survival Using Pooled Epidemiologic Cohort Data
BACKGROUND: Intensive systolic blood pressure treatment (<120 mm Hg) in SPRINT (Systolic Blood Pressure Intervention Trial) improved survival compared with standard treatment (<140 mm Hg) over a median follow‐up of 3.3 years. We projected life expectancy after observed follow‐up in SPRINT usin...
Autores principales: | Bellows, Brandon K., Zhang, Yiyi, Zhang, Zugui, Lloyd‐Jones, Donald M., Bress, Adam P., King, Jordan B., Kolm, Paul, Cushman, William C., Johnson, Karen C., Tamariz, Leonardo, Oelsner, Elizabeth C., Shea, Steven, Newman, Anne B., Ives, Diane G., Couper, David, Moran, Andrew E., Weintraub, William S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200698/ https://www.ncbi.nlm.nih.gov/pubmed/33955229 http://dx.doi.org/10.1161/JAHA.120.020361 |
Ejemplares similares
-
Posttrial Access to Medical Interventions: Intricacies, Challenges, and Solutions
por: Singh, Harmanjit, et al.
Publicado: (2019) -
Continued Posttrial Benefits of Buprenorphine Extended Release: RECOVER Study Findings
por: Boyett, Brent, et al.
Publicado: (2023) -
Patterns of warfarin use and subsequent outcomes in atrial fibrillation in primary care practices
por: Ewen, Edward, et al.
Publicado: (2012) -
Temporal Validation of the UKPDS Outcomes Model Using 10-Year Posttrial Monitoring Data
por: Leal, Jose, et al.
Publicado: (2013) -
Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment
por: Weintraub, William S., et al.
Publicado: (2022)